178 related articles for article (PubMed ID: 31848295)
1. Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.
Chang LS; Oblinger JL; Burns SS; Huang J; Anderson LW; Hollingshead MG; Shen R; Pan L; Agarwal G; Ren Y; Roberts RD; O'Keefe BR; Kinghorn AD; Collins JM
Mol Cancer Ther; 2020 Mar; 19(3):731-741. PubMed ID: 31848295
[TBL] [Abstract][Full Text] [Related]
2. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
Oblinger JL; Burns SS; Akhmametyeva EM; Huang J; Pan L; Ren Y; Shen R; Miles-Markley B; Moberly AC; Kinghorn AD; Welling DB; Chang LS
Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
[TBL] [Abstract][Full Text] [Related]
3. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 inhibition induces cell apoptosis through dual suppression of CXCR4 and Ras pathways in human malignant peripheral nerve sheath tumors.
Shih TC; Fan Y; Kiss S; Li X; Deng XN; Liu R; Chen XJ; Carney R; Chen A; Ghosh PM; Lam KS
Neuro Oncol; 2019 Nov; 21(11):1389-1400. PubMed ID: 31127849
[TBL] [Abstract][Full Text] [Related]
5. Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts.
Butler E; Schwettmann B; Geboers S; Hao G; Kim J; Nham K; Sun X; Laetsch TW; Xu L; Williams NS; Skapek SX
Pediatr Blood Cancer; 2020 Dec; 67(12):e28639. PubMed ID: 32975370
[TBL] [Abstract][Full Text] [Related]
6. Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7.
Kim S; Hwang BY; Su BN; Chai H; Mi Q; Kinghorn AD; Wild R; Swanson SM
Anticancer Res; 2007; 27(4B):2175-83. PubMed ID: 17695501
[TBL] [Abstract][Full Text] [Related]
7. Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
Gampala S; Shah F; Zhang C; Rhodes SD; Babb O; Grimard M; Wireman RS; Rad E; Calver B; Bai RY; Staedtke V; Hulsey EL; Saadatzadeh MR; Pollok KE; Tong Y; Smith AE; Clapp DW; Tee AR; Kelley MR; Fishel ML
Br J Cancer; 2021 Apr; 124(9):1566-1580. PubMed ID: 33658640
[TBL] [Abstract][Full Text] [Related]
8. Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo.
Schulte A; Ewald F; Spyra M; Smit DJ; Jiang W; Salamon J; Jücker M; Mautner VF
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102484
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol.
Cencic R; Carrier M; Galicia-Vázquez G; Bordeleau ME; Sukarieh R; Bourdeau A; Brem B; Teodoro JG; Greger H; Tremblay ML; Porco JA; Pelletier J
PLoS One; 2009; 4(4):e5223. PubMed ID: 19401772
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer.
Kogure T; Kinghorn AD; Yan I; Bolon B; Lucas DM; Grever MR; Patel T
PLoS One; 2013; 8(9):e76136. PubMed ID: 24086701
[TBL] [Abstract][Full Text] [Related]
11. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
[TBL] [Abstract][Full Text] [Related]
12. Silvestrol induces early autophagy and apoptosis in human melanoma cells.
Chen WL; Pan L; Kinghorn AD; Swanson SM; Burdette JE
BMC Cancer; 2016 Jan; 16():17. PubMed ID: 26762417
[TBL] [Abstract][Full Text] [Related]
13. Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.
Pan L; Woodard JL; Lucas DM; Fuchs JR; Kinghorn AD
Nat Prod Rep; 2014 Jul; 31(7):924-39. PubMed ID: 24788392
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic rocaglamide derivatives from Aglaia duppereana.
El-Neketi M; Ebrahim W; Duong NT; Gedara S; Badria F; Saad HE; Müller WE; Proksch P
Z Naturforsch C J Biosci; 2013; 68(7-8):269-74. PubMed ID: 24066511
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).
Li-Weber M
Int J Cancer; 2015 Oct; 137(8):1791-9. PubMed ID: 24895251
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of rocaglamide hydroxamates and related compounds as eukaryotic translation inhibitors: synthetic and biological studies.
Rodrigo CM; Cencic R; Roche SP; Pelletier J; Porco JA
J Med Chem; 2012 Jan; 55(1):558-62. PubMed ID: 22128783
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
[TBL] [Abstract][Full Text] [Related]
18. Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor.
Kivlin CM; Watson KL; Al Sannaa GA; Belousov R; Ingram DR; Huang KL; May CD; Bolshakov S; Landers SM; Kalam AA; Slopis JM; McCutcheon IE; Pollock RE; Lev D; Lazar AJ; Torres KE
Cancer Biol Ther; 2016; 17(2):129-38. PubMed ID: 26650448
[TBL] [Abstract][Full Text] [Related]
19. Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase.
Lee MJ; Tsai YJ; Lin MY; You HL; Kalyanam N; Ho CT; Pan MH
Phytomedicine; 2019 Apr; 57():377-384. PubMed ID: 30831486
[TBL] [Abstract][Full Text] [Related]
20. Rocaglaol induces apoptosis and cell cycle arrest in LNCaP cells.
Mi Q; Su BN; Chai H; Cordell GA; Farnsworth NR; Kinghorn AD; Swanson SM
Anticancer Res; 2006; 26(2A):947-52. PubMed ID: 16619491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
